Eramian Daniel G 4
4 · CELL THERAPEUTICS INC · Filed Jun 29, 2012
Insider Transaction Report
Form 4
Eramian Daniel G
EVP, Corporate Communications
Transactions
- Award
Common Stock
2012-06-27+27,415→ 1,991,761 total - Sale
Common Stock
2012-06-28$0.57/sh−3,000$1,704→ 1,988,761 total - Sale
Common Stock
2012-06-28$0.58/sh−10,000$5,760→ 1,961,761 total - Sale
Common Stock
2012-06-28$0.57/sh−269$154→ 1,971,761 total - Sale
Common Stock
2012-06-28$0.57/sh−200$114→ 1,988,561 total - Sale
Common Stock
2012-06-28$0.58/sh−20,000$11,600→ 1,941,761 total - Sale
Common Stock
2012-06-28$0.57/sh−6,800$3,876→ 1,981,761 total - Sale
Common Stock
2012-06-28$0.57/sh−9,731$5,556→ 1,972,030 total
Footnotes (1)
- [F1]As disclosed by CTIC in a Form 8-K filed on 12/1/11, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC stock upon the achievement of certain performance goals. The shares reported above on this Form 4 reflect the issuance of vested stock by CTIC pursuant to the award in connection with the achievement of the Pixantrone MAA Approval goal under the award.